GANX NASDAQ
Gain Therapeutics, Inc.
1W: -3.9%
1M: -4.5%
3M: -5.5%
YTD: -46.2%
1Y: -6.0%
3Y: -46.7%
5Y: -77.0%
$1.71
-0.01 (-0.58%)
Weekly Expected Move ±7.2%
$1
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — GANX
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (21)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 70.3 | 71.7 | 71.6 | 71.2 | SEC ↗ |
| 2026-03-31 | 10-Q | 69.4 | 72.0 | 71.6 | 71.0 | SEC ↗ |
| 2025-12-31 | 10-K | 60.3 | 63.6 | 63.1 | 62.4 | SEC ↗ |
| 2025-09-30 | 10-Q | 68.5 | 72.2 | 72.9 | 71.2 | SEC ↗ |
| 2025-06-30 | 10-Q | 67.5 | 72.0 | 72.7 | 70.7 | SEC ↗ |
| 2025-03-31 | 10-Q | 69.8 | 70.8 | 71.6 | 70.7 | SEC ↗ |
| 2024-12-31 | 10-K | 61.6 | 63.8 | 62.4 | 62.6 | SEC ↗ |
| 2024-09-30 | 10-Q | 57.0 | 63.2 | 62.6 | 60.9 | SEC ↗ |
| 2024-06-30 | 10-Q | 58.0 | 63.2 | 62.3 | 61.2 | SEC ↗ |
| 2024-03-31 | 10-Q | 57.4 | 63.2 | 62.2 | 60.9 | SEC ↗ |
| 2023-12-31 | 10-K | 59.4 | 64.4 | 63.8 | 62.5 | SEC ↗ |
| 2023-09-30 | 10-Q | 58.8 | 62.6 | 62.6 | 61.3 | SEC ↗ |
| 2023-06-30 | 10-Q | 58.2 | 62.6 | 62.5 | 61.1 | SEC ↗ |
| 2023-03-31 | 10-Q | 57.8 | 62.2 | 62.7 | 60.9 | SEC ↗ |
| 2022-12-31 | 10-K | 58.1 | 63.5 | 62.5 | 61.4 | SEC ↗ |
| 2022-09-30 | 10-Q | 60.9 | 62.6 | 63.5 | 62.4 | SEC ↗ |
| 2022-06-30 | 10-Q | 59.5 | 62.2 | 63.5 | 61.8 | SEC ↗ |
| 2022-03-31 | 10-Q | 59.5 | 61.4 | 63.3 | 61.4 | SEC ↗ |
| 2021-12-31 | 10-K | 59.1 | 62.8 | 64.2 | 62.1 | SEC ↗ |
| 2021-09-30 | 10-Q | 60.7 | 62.1 | 66.1 | 63.0 | SEC ↗ |
| 2021-06-30 | 10-Q | 60.5 | 62.1 | 66.7 | 63.1 | SEC ↗ |